EX-VIVO ELIMINATION OF CHRONIC MYELOID-LEUKEMIA (CML) CELLS FOLLOWING ACTIVATION AND TARGETING OF HOST T-CELLS BY COMBINATION OF CYTOKINES AND CD3 MONOCLONAL-ANTIBODIES

被引：0
|
作者：
NOTTER, M [1 ]
MAURER, J [1 ]
KRACKHARDT, A [1 ]
HENKEL, B [1 ]
HENZE, K [1 ]
BOCHERT, G [1 ]
LUDWIG, WD [1 ]
BERDEL, WE [1 ]
THIEL, E [1 ]
机构：
[1] FREE UNIV BERLIN,KLINIKUM STEGLITZ,DEPT HEMATOL ONCOL,W-1000 BERLIN 45,GERMANY
来源：
BLOOD | 1993年 / 82卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A247 / A247
页数：1
相关论文
共 20 条
  • [1] REQUIREMENTS FOR ACTIVATION OF HUMAN PERIPHERAL-BLOOD T-CELLS BY MOUSE MONOCLONAL-ANTIBODIES TO CD3
    UMETSU, DT
    KATZEN, D
    CHATILA, T
    MILLER, R
    JABARA, HH
    MAHER, M
    OETTGEN, H
    TERHORST, C
    GEHA, RS
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1987, 43 (01): : 48 - 64
  • [2] Selective lysis of acute myeloid leukemia cells by CD34/CD3 bispecific antibody through the activation of γδ T-cells
    Al Agrafi, Faisal
    Gaballa, Ahmed
    Hahn, Paula
    Arruda, Lucas C. M.
    Jaramillo, Adrian C.
    Witsen, Maartje
    Lehmann, Soeren
    Onfelt, Bjoern
    Uhlin, Michael
    Stikvoort, Arwen
    ONCOIMMUNOLOGY, 2024, 13 (01):
  • [3] HUMAN NAIVE T-CELLS ARE PREFERENTIALLY STIMULATED BY CROSS-LINKING OF CD3 AND CD45RA WITH MONOCLONAL-ANTIBODIES
    WELGE, T
    WOLF, M
    JAGGLE, C
    LUCKENBACH, GA
    CELLULAR IMMUNOLOGY, 1993, 148 (01) : 218 - 225
  • [4] CD30-ANTIGEN-SPECIFIC TARGETING AND ACTIVATION OF T-CELLS VIA MURINE BISPECIFIC MONOCLONAL-ANTIBODIES AGAINST CD3 AND CD28 - POTENTIAL USE FOR THE TREATMENT OF HODGKINS LYMPHOMA
    POHL, C
    DENFELD, R
    RENNER, C
    JUNG, W
    BOHLEN, H
    SAHIN, U
    HOMBACH, A
    VANLIER, R
    SCHWONZEN, M
    DIEHL, V
    PFREUNDSCHUH, M
    INTERNATIONAL JOURNAL OF CANCER, 1993, 54 (05) : 820 - 827
  • [5] CD19/CD3 bispecific antibodies induce potent response against chronic lymphocytic leukemia cells ex vivo
    Robinson, Hannah Ruth
    Qi, Junpeng
    Baskar, Sivasubramanian
    Rader, Christoph
    Wiestner, Adrian
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [6] USE OF ANTI-CD3 AND ANTI-CD16 BISPECIFIC MONOCLONAL-ANTIBODIES FOR THE TARGETING OF T-CELLS AND NK CELLS AGAINST TUMOR-CELLS
    FERRINI, S
    CAMBIAGGI, A
    SFORZINI, S
    CANEVARI, S
    MEZZANZANICA, D
    COLNAGHI, MI
    MORETTA, L
    CANCER DETECTION AND PREVENTION, 1993, 17 (02): : 295 - 300
  • [7] CD3 MONOCLONAL-ANTIBODIES EVOKE THE SAME CYTOCHROME-P450-REGULATED CAPACITATIVE ENTRY OF CALCIUM AS THAPSIGARGIN IN JURKAT T-CELLS
    BREITTMAYER, JP
    BERTHE, P
    COUSIN, JL
    BERNARD, A
    AUSSEL, C
    CELLULAR IMMUNOLOGY, 1993, 152 (01) : 143 - 151
  • [8] Artificial antigen presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies are highly effective to induce the ex vivo expansion of functional human antitumour T-cells
    Zappasodi, R.
    Di Nicola, M.
    Carlo-Stella, C.
    Mortarini, R.
    Molla, A.
    Vegetti, C.
    Albani, S.
    Anichini, A.
    Gianni, A. M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S165 - S165
  • [9] REGULATION OF HUMAN B-CELL RESPONSIVENESS BY CD8+ T-CELLS - DIFFERENTIAL-EFFECTS OF STIMULATION WITH MONOCLONAL-ANTIBODIES TO CD3 AND POKEWEED MITOGEN
    HIROHATA, S
    PATEL, SS
    LIPSKY, PE
    CELLULAR IMMUNOLOGY, 1990, 127 (01) : 35 - 46
  • [10] CD30-ANTIGEN-SPECIFIC TARGETING AND ACTIVATION OF T-CELLS VIA MURINE BISPECIFIC MONOCLONAL-ANTIBODIES AGAINST CD3 AND CD28 - POTENTIAL USE FOR THE TREATMENT OF HODGKINS LYMPHOMA (VOL 54, PG 820, 1993)
    POHL, C
    DENFELD, R
    RENNER, C
    JUNG, W
    BOHLEN, H
    SAHIN, U
    HOMBACH, A
    VANLIER, R
    SCHWONZEN, M
    DIEHL, V
    PFREUNDSCHUH, M
    INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (02) : 294 - 294
12